Pfizer
One of the world's largest pharmaceutical companies — vaccines, oncology, and the drug pipeline behind them.
Coverage of Pfizer is holding steady : 6 signals on the latest tracked day, up 100% from its three-week baseline of 3, across 2 domains (down from 3 a week ago). That makes it the #113 most-covered of the 274 concerns we track.
What’s changed
- STAT+: Pharmalittle: We’re reading about a Medicare pilot and orphan drugs, Pfizer cutbacks, and more · STAT News — All Content · 2026-08-06
- Pfizer expands multibillion-dollar cost-cutting plan · Reddit r/biotech · 2026-08-06
- Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launch · BioPharma Dive — Latest News · 2026-08-06
- Pfizer unveils additional $2.5B in planned cost savings through 2029 · Fierce Pharma · 2026-08-05
- Pfizer axes ex-Metsera obesity asset and GIPR prospect in quarterly clearout · Fierce Biotech · 2026-08-05
- Pfizer takes Litfulo to regulators in vitiligo challenge to Incyte, AbbVie · Fierce Pharma · 2026-07-31
What the reporting says
Across 51 tracked stories from 19 outlets, reporting on Pfizer most often describes regulatory approvals (8), launches or releases (6), funding rounds (1), IPOs or listings (1), legal rulings (1), acquisition (1).
It shows up alongside Bristol Myers Squibb (16), Astrazeneca (15), Novartis (13), FDA (14), Merck (14), Eli Lilly (13).
Two steps out: AI (through FDA, 14 shared stories on the weaker link); China (through FDA, 14 shared stories on the weaker link); CMS (through FDA, 14 shared stories on the weaker link); Colorectal Cancer (through FDA, 14 shared stories on the weaker link).
Tracked since Jun 25, with coverage on 19 separate days — concentrated in Biotech Pharma and Pharma Pipeline.